Identification of promising anti-EBOV inhibitors: de novo drug design, molecular docking and molecular dynamics studies

por Mohamed, Eslam A. R., Abdelwahab, Sayed F., Alqaisi, Ahmad M., Nasr, Amaal Mohammed Salih, Hassan, Heba Ali
Publicado 2022

Conducting the RBD of SARS-CoV-2 Omicron Variant with Phytoconstituents from Euphorbia dendroides to Repudiate the Binding of Spike Glycoprotein Using Computational Molecular Searc...

por Hassan, Heba Ali, Hassan, Ahmed R., Mohamed, Eslam A.R., Al-Khdhairawi, Ahmad, Karkashan, Alaa, Attar, Roba, Allemailem, Khaled S., Al Abdulmonem, Waleed, Shimizu, Kuniyoshi, Abdel-Rahman, Iman A. M., Allam, Ahmed E.
Publicado 2022

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study

por Ibrahim, Mahmoud A.A., Mohamed, Eslam A.R., Abdelrahman, Alaa H.M., Allemailem, Khaled S., Moustafa, Mahmoud F., Shawky, Ahmed M., Mahzari, Ali, Hakami, Abdulrahim Refdan, Abdeljawaad, Khlood A.A., Atia, Mohamed A.M.
Publicado 2021

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing

por Mohamed, Eslam A. R., Abdel-Rahman, Islam M., Zaki, Magdi E. A., Al-Khdhairawi, Ahmad, Abdelhamid, Mahmoud M., Alqaisi, Ahmad M., Rahim, Lyana binti Abd, Abu-Hussein, Bilal, El-Sheikh, Azza A. K., Abdelwahab, Sayed F., Hassan, Heba Ali
Publicado 2023

Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study

por Hassan, Heba Ali, Hassan, Ahmed R., Mohamed, Eslam A. R., Al-Khdhairawi, Ahmad, Taha, Hala E., El-Tantawy, Hanan M., Abdel-Rahman, Iman A. M., Raslan, Ali E., Allemailem, Khaled S., Almatroudi, Ahmad, Alrumaihi, Faris, Alshiekheid, Maha A., Rehman, Hafiz Muzzammel, Abdelhamid, Mahmoud M., Abdel-Rahman, Islam M., Allam, Ahmed E.
Publicado 2022